JP2025023916A5 - - Google Patents

Download PDF

Info

Publication number
JP2025023916A5
JP2025023916A5 JP2024178540A JP2024178540A JP2025023916A5 JP 2025023916 A5 JP2025023916 A5 JP 2025023916A5 JP 2024178540 A JP2024178540 A JP 2024178540A JP 2024178540 A JP2024178540 A JP 2024178540A JP 2025023916 A5 JP2025023916 A5 JP 2025023916A5
Authority
JP
Japan
Prior art keywords
rna molecule
pharmaceutical composition
secretion
immunostimulatory
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024178540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025023916A (ja
Filing date
Publication date
Priority claimed from PCT/EP2018/057206 external-priority patent/WO2018172426A1/en
Application filed filed Critical
Publication of JP2025023916A publication Critical patent/JP2025023916A/ja
Publication of JP2025023916A5 publication Critical patent/JP2025023916A5/ja
Pending legal-status Critical Current

Links

JP2024178540A 2017-03-24 2024-10-11 免疫応答を刺激するための方法及び組成物 Pending JP2025023916A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EPPCT/EP2017/057094 2017-03-24
EP2017057094 2017-03-24
PCT/EP2018/057206 WO2018172426A1 (en) 2017-03-24 2018-03-21 Methods and compositions for stimulating immune response
JP2019551991A JP7651261B2 (ja) 2017-03-24 2018-03-21 免疫応答を刺激するための方法及び組成物
JP2022193597A JP2023036615A (ja) 2017-03-24 2022-12-02 免疫応答を刺激するための方法及び組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022193597A Division JP2023036615A (ja) 2017-03-24 2022-12-02 免疫応答を刺激するための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2025023916A JP2025023916A (ja) 2025-02-19
JP2025023916A5 true JP2025023916A5 (cg-RX-API-DMAC7.html) 2025-03-03

Family

ID=61911533

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019551991A Active JP7651261B2 (ja) 2017-03-24 2018-03-21 免疫応答を刺激するための方法及び組成物
JP2022193597A Pending JP2023036615A (ja) 2017-03-24 2022-12-02 免疫応答を刺激するための方法及び組成物
JP2024178540A Pending JP2025023916A (ja) 2017-03-24 2024-10-11 免疫応答を刺激するための方法及び組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019551991A Active JP7651261B2 (ja) 2017-03-24 2018-03-21 免疫応答を刺激するための方法及び組成物
JP2022193597A Pending JP2023036615A (ja) 2017-03-24 2022-12-02 免疫応答を刺激するための方法及び組成物

Country Status (6)

Country Link
US (3) US11471522B2 (cg-RX-API-DMAC7.html)
EP (2) EP4241786A3 (cg-RX-API-DMAC7.html)
JP (3) JP7651261B2 (cg-RX-API-DMAC7.html)
AU (1) AU2018240421B2 (cg-RX-API-DMAC7.html)
ES (1) ES2951684T3 (cg-RX-API-DMAC7.html)
WO (1) WO2018172426A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018240421B2 (en) 2017-03-24 2025-03-06 BioNTech SE Methods and compositions for stimulating immune response
AU2021252164B2 (en) 2020-04-09 2026-07-02 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
WO2022099003A1 (en) * 2020-11-06 2022-05-12 Sanofi Lipid nanoparticles for delivering mrna vaccines
CN114733455B (zh) * 2022-04-15 2023-02-14 北京田园奥瑞生物科技有限公司 一种利用生物改性β-环糊精纳米磁颗粒进行快速哺乳动物精子分型的方法
AU2024409925A1 (en) 2023-12-26 2026-08-06 Emmune, Inc. Systems for nucleic acid transfer
WO2025223684A1 (en) 2024-04-23 2025-10-30 BioNTech SE Methods and compositions for stimulating immune response

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007526253A (ja) * 2004-02-19 2007-09-13 コーリー ファーマシューティカル グループ,インコーポレイテッド 免疫刺激性ウイルスrnaオリゴヌクレオチド
EP2167662A2 (en) * 2007-05-14 2010-03-31 Technische Universität München Pharmaceutical compounds comprising abasic oligonucleotides
EP3263707A1 (en) * 2009-03-17 2018-01-03 Rheinische Friedrich-Wilhelms-Universität Bonn Tlr8 ligand and uses thereof
US8840902B2 (en) * 2010-03-16 2014-09-23 Biontech Ag Tumor vaccination involving a humoral immune response against self-proteins
US9518260B2 (en) * 2012-02-29 2016-12-13 Benitec Biopharma Limited Pain treatment
US10624964B2 (en) 2015-05-01 2020-04-21 The Trustees Of The University Of Pennsylvania Methods and compositions for stimulating immune response using potent immunostimulatory RNA motifs
MA46023A (fr) 2015-10-22 2019-07-03 Modernatx Inc Vaccin contre le virus de la grippe à large spectre
AU2018240421B2 (en) * 2017-03-24 2025-03-06 BioNTech SE Methods and compositions for stimulating immune response

Similar Documents

Publication Publication Date Title
Wang et al. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
Janke et al. Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy
JP2023176003A5 (cg-RX-API-DMAC7.html)
Sakai et al. Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells.
Portier et al. In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma
JP2021524270A5 (cg-RX-API-DMAC7.html)
WO2019080537A1 (zh) 包含溶瘤病毒和car-nk细胞的治疗剂及应用、药盒、治疗肿瘤和/或癌症的方法
WO2018228538A1 (zh) 重组单纯疱疹病毒及其制备方法和应用
JP2021525519A5 (cg-RX-API-DMAC7.html)
WO2019062233A1 (zh) 包含分离的重组溶瘤痘病毒和nk细胞的治疗剂及应用、药盒、治疗肿瘤和/或癌症的方法
Sanchez et al. Expression of inducible CC chemokines in rainbow trout (Oncorhynchus mykiss) in response to a viral haemorrhagic septicemia virus (VHSV) DNA vaccine and interleukin 8
US11098283B2 (en) T cells modified to overexpress c-Myb
CN112262212B (zh) 使用羟基柠檬酸和/或其盐产生t细胞群体的方法
JP2022502066A5 (cg-RX-API-DMAC7.html)
CN109415410B (zh) 靶向树突细胞的肽、利用了该肽的肽融合体、及利用了该肽融合体的疫苗
CN101063142B (zh) 人乳头瘤病毒16型dna疫苗和基因佐剂及其应用
CN108486120B (zh) 一种新型CpG ODN序列及其在抗黑色素瘤上的应用
CN103547286B (zh) 一种用于预防和治疗乙型肝炎的dna疫苗组合物
CN87102457A (zh) 初级细胞的永久化
CN105797147A (zh) Cxcl13 dna疫苗及其应用
CN105037559A (zh) 治疗或预防乙肝的细胞毒性t淋巴细胞及其制备方法
CN118221773B (zh) 与HLA相关的CMV pp65表位疫苗组合物与应用
EP2647645A1 (en) Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
CN121950744A (zh) 一种针对福建牡蛎主要致敏原的t细胞表位融合蛋白及其应用
EP4029515A1 (en) Anti-infection effects of hnrnpa2b1 and use thereof